Italia markets close in 7 hours 18 minutes

Affiliated Managers Group, Inc. (AMG)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
162,07+0,60 (+0,37%)
Alla chiusura: 04:00PM EDT
162,07 0,00 (0,00%)
Dopo ore: 06:02PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente161,47
Aperto160,91
Denaro162,54 x 3100
Lettera162,72 x 800
Min-Max giorno160,91 - 162,71
Intervallo di 52 settimane120,22 - 169,65
Volume181.302
Media Volume236.588
Capitalizzazione5,26B
Beta (5 anni mensile)1,32
Rapporto PE (ttm)9,30
EPS (ttm)17,42
Prossima data utili29 apr 2024 - 03 mag 2024
Rendimento e dividendo (futuro)0,04 (0,02%)
Data ex dividendo14 feb 2024
Stima target 1A197,00
  • GlobeNewswire

    AMG Appoints Loren M. Starr to its Board of Directors

    WEST PALM BEACH, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- AMG, a leading partner to independent investment management firms globally, today announced the appointment of Loren M. Starr to its Board of Directors, effective immediately. Mr. Starr retired from Invesco Ltd. in March 2021, having served as Chief Financial Officer of the company for 15 years, from 2005 to 2020, after which he held an executive advisory role as Invesco’s Vice Chair until his retirement. Prior to joining Invesco in 2005,

  • GlobeNewswire

    AMG Completes Investment in Forbion

    WEST PALM BEACH, Fla., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Affiliated Managers Group, Inc. (NYSE: AMG), a leading partner to independent investment management firms globally, today announced the completion of its investment in Forbion Group Holding B.V. (“Forbion”). Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. With approximately €3 billion in assets under management, For

  • GlobeNewswire

    AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2023

    Company reports EPS of $3.25, Economic EPS of $4.45 in the second quarter of 2023 Announced partnership with Forbion, a leading European life sciences venture capital and growth equity firmNet Income (controlling interest) of $125 million, Economic Net Income of $167 millionEconomic Earnings per share of $4.45 increased 10% year-over-yearCompleted $225 million accelerated share repurchase program and repurchased an additional $44 million of common stockGross proceeds of approximately $294 millio